129 related articles for article (PubMed ID: 6294785)
1. Antimicrobial activity of desacetylcefotaxime alone and in combination with cefotaxime: evidence of synergy.
Jones RN; Barry AL; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S366-73. PubMed ID: 6294785
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of desacetylcefotaxime alone and in combination with cefotaxime.
Neu HC
Rev Infect Dis; 1982; 4 Suppl():S374-8. PubMed ID: 6294786
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
Oizumi K; Hayashi I; Aonuma S; Konno K
Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
[TBL] [Abstract][Full Text] [Related]
4. Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism.
Chin NX; Neu HC
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):21S-31S. PubMed ID: 6086215
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
Jones RN; Barry AL
Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
[TBL] [Abstract][Full Text] [Related]
6. [In vitro synergy between cefotaxime and its main metabolite, desacetylcefotaxime].
Kobayashi S; Arai S; Hayashi S; Sakaguchi T; Kawana R
Jpn J Antibiot; 1988 May; 41(5):594-601. PubMed ID: 3216482
[TBL] [Abstract][Full Text] [Related]
7. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
Aldridge KE; Sanders CV; Marier RL
Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
Jenkins SG; Lewis JW
Infection; 1995; 23(3):154-61. PubMed ID: 7499004
[TBL] [Abstract][Full Text] [Related]
10. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro studies on cefotaxime and desacetylcefotaxime.
Selwyn S; Bakhtiar M
Drugs Exp Clin Res; 1986; 12(12):953-65. PubMed ID: 3494587
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Aldridge KE
Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
[TBL] [Abstract][Full Text] [Related]
13. The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.
Devlin HR; Boskovski L
Drugs; 1988; 35 Suppl 2():45-50. PubMed ID: 3396488
[TBL] [Abstract][Full Text] [Related]
14. In vitro comparison of the activity of cefotaxime and desacetylated cefotaxime and of their combination.
Nanetti A; La Placa M
J Chemother; 1990 Jun; 2(3):159-63. PubMed ID: 2380765
[TBL] [Abstract][Full Text] [Related]
15. An in vitro study of the interaction between cefotaxime and desacetylcefotaxime.
Winstanley TG; Spencer RC
Drugs Exp Clin Res; 1986; 12(12):967-71. PubMed ID: 3471432
[TBL] [Abstract][Full Text] [Related]
16. Cefotaxime: a review of in vitro antimicrobial properties and spectrum of activity.
Jones RN; Thornsberry C
Rev Infect Dis; 1982; 4 Suppl():S300-15. PubMed ID: 6294779
[TBL] [Abstract][Full Text] [Related]
17. [In vitro evaluation of the activity and interactions of cefotaxime and its metabolite desacetylcefotaxime against strains of enterobacteria, staphylococci and Bacteroides fragilis isolated from hospital infections].
Pitzus E
G Ital Chemioter; 1989; 36(1-3):57-64. PubMed ID: 2488914
[TBL] [Abstract][Full Text] [Related]
18. Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations.
Jones RN; Packer RR
Diagn Microbiol Infect Dis; 1984 Jan; 2(1):65-8. PubMed ID: 6100364
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of cefotaxime and desacetylcefotaxime against the Bacteroides fragilis group.
Cornick NA; Gorbach SL
Diagn Microbiol Infect Dis; 1988 Jun; 10(2):81-4. PubMed ID: 3224498
[TBL] [Abstract][Full Text] [Related]
20. The activity of cefotaxime and desacetylcefotaxime against Bacteroides species compared to 7-methoxy cephems and other anti-anaerobe drugs.
Jones RN
J Antimicrob Chemother; 1984 Sep; 14 Suppl B():39-43. PubMed ID: 6094461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]